Atlas Trials

Gabapentin in Patients at Clinical Risk for Psychosis

Clinical trial NCT02557945 · TERMINATED

Trial details

NCT number
NCT02557945
Sponsor
New York State Psychiatric Institute
Status
TERMINATED
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
Clinical High Risk for Psychosis
Start date
2015-08-01
Primary completion
2016-06-12
Enrollment
9

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.